Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|178|2|320-321

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.178, Iss.2, 2018-02, pp. : 320-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost‐effectiveness analysis of the BLISTER trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 415-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 17-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sera of Elderly Bullous Pemphigoid Patients with Associated Neurological Diseases Recognize Bullous Pemphigoid Antigens in the Human Brain

By  

Gerontology, Vol. 57, Iss. 3, 2010-07 ,pp. : 211-216

Karger

Access to resources Recommend Favorite

T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 180, Iss. 2, 2015-05 ,pp. : 189-200

John Wiley & Sons Inc

Access to resources Recommend Favorite